JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'gsk 3 inhibitor 1'

Search results for: 'gsk 3 inhibitor 1'

B5864 Fruquintinib(HMPL-013)

Target: VEGFR

Summary: Potent and selective inhibitor of VEGFR 1, 2, 3

insoluble in H2O; insoluble in EtOH; ≥6.35 mg/mL
A8456 JTC-801

Target: NOP Receptors

Summary: KOR-3 (NOP) receptor antagonist

≥22.4 mg/mL
A4135 Tofacitinib (CP-690550) Citrate

2 Citation

Target: JAK

Summary: Potent JAK inhibitor

≥25.22 mg/mL
A3736 PRT062607 Hydrochloride

1 Citation

Target: Syk

Summary: SYK inhibitor,potent and selective

≥21.5 mg/mL
A4121 SNS-314 Mesylate

Target: Aurora Kinases

Summary: Aurora A/B/C kinases inhibitor, potent and selective

≥26.35 mg/mL
B6367 NPPB

Target: Calcium-activated chloride channels (CaCC)|GPR35

Summary: inhibitor of chloride channel

insoluble in EtOH; insoluble in H2O; ≥11.05 mg/mL
A8370 Axitinib (AG 013736)

1 Citation

Target: VEGFR|PDGFR|c-Kit

Summary: VEGFR1/ c-Kit inhibitor

insoluble in H2O; ≥19.3 mg/mL
B1536 AZD1080

1 Citation

Target: GSK-3

Summary: GSK3βinhibitor

insoluble in H2O; insoluble in EtOH; ≥16.7 mg/mL
A3014 BGJ398

1 Citation

Target: FGFR

Summary: FGFR inhibitor ,potent and selective

insoluble in H2O; insoluble in EtOH; ≥7 mg/mL
A8217 ICG 001

1 Citation

Summary: Wnt/β-catenin pathway inhibitor

≥27.43 mg/mL